FIGURE 2
FROM:
Loss of BMI-1 expression is associated with clinical progress of malignant melanoma
Ingeborg M Bachmann, Hanne E Puntervoll, Arie P Otte and Lars A Akslen
BACK TO ARTICLEFigure 2.

Immunoreactivity for BMI-1 in cutaneous melanoma of vertical growth phase, showing (a) strong and (b) negative protein expression for the F6 antibody.
